DiaSorin Revenue and Competitors

Stillwater, MN USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • DiaSorin's estimated annual revenue is currently $38M per year.(i)
  • DiaSorin's estimated revenue per employee is $155,000

Employee Data

  • DiaSorin has 245 Employees.(i)
  • DiaSorin grew their employee count by 47% last year.

DiaSorin's People

NameTitleEmail/Phone
1
VP, Regulatory and Clinical Affairs, North AmericaReveal Email/Phone
2
VP, Legal Affairs North AmericaReveal Email/Phone
3
VP Operations and Product DevelopmentReveal Email/Phone
4
Sr. Director, National AccountsReveal Email/Phone
5
Director, Quality AssuranceReveal Email/Phone
6
Director Supply ChainReveal Email/Phone
7
Senior Director Program Management OfficeReveal Email/Phone
8
Director Manufacturing and Quality ControlReveal Email/Phone
9
Director Product MarketingReveal Email/Phone
10
National Service DirectorReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$17532.8M1131152%N/AN/A
#2
$42310M1699955%N/A$226.6B
Add Company

What Is DiaSorin?

Are you ready to make an impact at DiaSorin? We seek out employees who are inspired by our mission and who thrive in our collaborative, fast paced and entrepreneurial culture

keywords:N/A

N/A

Total Funding

245

Number of Employees

$38M

Revenue (est)

47%

Employee Growth %

N/A

Valuation

N/A

Accelerator

DiaSorin News

2022-04-20 - Thyroid Function Tests Market Size, Outlook And Forecast ...

Beckman Coulters, Siemens, DiaSorin, IBL-America. This comprehensive Thyroid Function Tests Market report helps in determining the deficiencies and problems...

2022-04-20 - Thyroid Function Tests Market Size, Outlook And Forecast ...

Beckman Coulters, Siemens, DiaSorin, IBL-America. This comprehensive Thyroid Function Tests Market report helps in determining the deficiencies and problems...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$35M2559%N/A
#2
$15M27517%N/A
#3
$46.7M2932%N/A
#4
$110.7M3286%N/A
#5
$113.1M3353%N/A